Concepedia

Publication | Open Access

Efficacy and safety of nivolumab (Nivo) + ipilimumab (Ipi) in patients (pts) with recurrent/metastatic (R/M) cervical cancer: Results from CheckMate 358

89

Citations

0

References

2019

Year

No additional data available for this publication yet. Check back later!